QUINOBARB TABLET 100MG DIN 00249424
Status: Cancelled Post Market
Holder: ROUGIER PHARMA DIVISION OF RATIOPHARM INC
Molecule: QUINIDINE PHENYLETHYLBARBITURATE
Health Canada record
| Active ingredient(s) | QUINIDINE PHENYLETHYLBARBITURATE 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Human |
| ATC | C01BA01 QUINIDINE |
| Original market date | 31-Dec-1948 |
| Current status date | 22-Sep-2003 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing QUINIDINE PHENYLETHYLBARBITURATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00392901 | NATISEDINE TAB 100MG | SABEX INC | Tablet | QUINIDINE PHENYLETHYLBARBITURATE 100 MG | Cancelled Post Market |
| 01928767 | PROSEDYL TAB 100MG | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | Tablet | QUINIDINE PHENYLETHYLBARBITURATE 100 MG | Cancelled Post Market |